ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
暂无分享,去创建一个
[1] C. Sirolla,et al. Apolipoprotein E Polymorphism as a Risk Factor for Vascular Disease in Diabetic Patients , 1995, Diabetes Care.
[2] G. Crepaldi,et al. Poster abstractIs apolipoprotein E4 a genetic risk factor for nephropathy in type II diabetes , 1994 .
[3] D. Arveiler,et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[4] H. Gröne,et al. The role of lipids in nephrosclerosis and glomerulosclerosis. , 1994, Atherosclerosis.
[5] M. Laakso,et al. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. , 1993, Atherosclerosis.
[6] Y. Yazaki,et al. Apolipoprotein E Polymorphism Is Associated With Plasma Cholesterol Response in a 7-day Hospitalization Study for Metabolic and Dietary Control in NIDDM , 1993, Diabetes Care.
[7] R. Klein,et al. Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.
[8] A. Fitzgerald,et al. Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.
[9] S. Halimi,et al. Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study). , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] K. Parhofer,et al. Apolipoprotein E Phenotype Frequency in Type II Diabetic Patients with Different Forms of Hyperlipoproteinemia , 1990, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[11] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[12] H. Gröne,et al. Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[13] M. Nieminen,et al. Apoprotein E Polymorphism and Coronary Artery Disease: Increased Prevalence of Apolipoprotein E‐4 in Angiographically Verified Coronary Patients , 1989, Arteriosclerosis.
[14] S. Levin,et al. Nephropathy in non-insulin-dependent diabetes mellitus. , 1988, The American journal of medicine.
[15] M. Karnovsky,et al. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. , 1988, Kidney international.